Shanghai Junshi Bioscienc... (SHJBF)
Shanghai Junshi Biosciences Statistics
Share Statistics
Shanghai Junshi Biosciences has 1.73B shares outstanding. The number of shares has increased by -18.02% in one year.
| Shares Outstanding | 1.73B |
| Shares Change (YoY) | -18.02% |
| Shares Change (QoQ) | -15.16% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -6.58 and the forward PE ratio is null. Shanghai Junshi Biosciences's PEG ratio is 0.61.
| PE Ratio | -6.58 |
| Forward PE | n/a |
| PS Ratio | 10 |
| Forward PS | n/a |
| PB Ratio | 2.09 |
| P/FCF Ratio | -5.27 |
| PEG Ratio | 0.61 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Shanghai Junshi Biosciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.25.
| Current Ratio | 2.24 |
| Quick Ratio | 2.02 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | -0.83 |
| Debt / FCF | -0.63 |
| Interest Coverage | -84.53 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $582,835.53 |
| Profits Per Employee | $-885,036.46 |
| Employee Count | 2,578 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 1.24 |
Taxes
| Income Tax | 43.99M |
| Effective Tax Rate | -1.77% |
Stock Price Statistics
The stock price has increased by -4.37% in the last 52 weeks. The beta is 0.74, so Shanghai Junshi Biosciences's price volatility has been higher than the market average.
| Beta | 0.74 |
| 52-Week Price Change | -4.37% |
| 50-Day Moving Average | 1.97 |
| 200-Day Moving Average | 1.78 |
| Relative Strength Index (RSI) | 98.7 |
| Average Volume (20 Days) | 31 |
Income Statement
In the last 12 months, Shanghai Junshi Biosciences had revenue of 1.5B and earned -2.28B in profits. Earnings per share was -2.32.
| Revenue | 1.5B |
| Gross Profit | 835.26M |
| Operating Income | -2.45B |
| Net Income | -2.28B |
| EBITDA | -2.16B |
| EBIT | -2.46B |
| Earnings Per Share (EPS) | -2.32 |
Balance Sheet
The company has 3.78B in cash and 1.79B in debt, giving a net cash position of 1.99B.
| Cash & Cash Equivalents | 3.78B |
| Total Debt | 1.79B |
| Net Cash | 1.99B |
| Retained Earnings | -9.06B |
| Total Assets | 10.84B |
| Working Capital | 2.28B |
Cash Flow
In the last 12 months, operating cash flow was -2.01B and capital expenditures -832.58M, giving a free cash flow of -2.85B.
| Operating Cash Flow | -2.01B |
| Capital Expenditures | -832.58M |
| Free Cash Flow | -2.85B |
| FCF Per Share | -2.89 |
Margins
Gross margin is 55.59%, with operating and profit margins of -163.19% and -151.85%.
| Gross Margin | 55.59% |
| Operating Margin | -163.19% |
| Pretax Margin | -165.71% |
| Profit Margin | -151.85% |
| EBITDA Margin | -143.6% |
| EBIT Margin | -163.19% |
| FCF Margin | -189.51% |
Dividends & Yields
SHJBF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for SHJBF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -1.5 |
| Piotroski F-Score | 3 |